title: [What management of malignant middle cerebral artery infarction in Sub-Saharan Africa?].
authors.forename: G F
authors.initials: GF
authors.lastname: Otiobanda
authors.forename: P M
authors.initials: PM
authors.lastname: Ossou-Nguiet
authors.forename: B F
authors.initials: BF
authors.lastname: Ellenga-Mbolla
authors.forename: M S
authors.initials: MS
authors.lastname: Ikama
authors.forename: T R
authors.initials: TR
authors.lastname: Gombet
mesh_terms: D000367:Age Factors; D000437:Alcoholism / Q000150:complications; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002423:Cause of Death; D003223:Congo; D003430:Cross-Sectional Studies; D057210:Delayed Diagnosis / Q000706:statistics & numerical data; D048909:Diabetes Complications; D004232:Diuretics / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D020244:Infarction, Middle Cerebral Artery / Q000628:therapy*; D008279:Magnetic Resonance Imaging / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012737:Sex Factors; D012907:Smoking
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics; D004234:Diuretics, Osmotic; D010975:Platelet Aggregation Inhibitors